The changing face of multiple sclerosis clinical trial populations

By Uitdehaag Bernard M.J.   Barkhof Frederik   Coyle Patricia K.   Gardner Jason D.   Jeffery Douglas R.   Mikol Daniel D.  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1529-1537

Informa Healthcare

Access to resources Recommend Favorite

Intravenous Immunoglobulins in Multiple Sclerosis: Results of the Austrian Immunoglobulin in Multiple Sclerosis (AIMS) Trial

By  

Transfusion Medicine and Hemotherapy, Vol. 26, Iss. 2, 2004-11 ,pp. : 42-47

Karger

Access to resources Recommend Favorite

PRISMS: the story of a pivotal clinical trial series in multiple sclerosis

By Cohen Bruce A.   Rivera Victor M.  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 827-838

Informa Healthcare

Access to resources Recommend Favorite

Genetic polymorphisms associated with the development and clinical course of multiple sclerosis (Review)

By            

International Journal of Molecular Medicine, Vol. 28, Iss. 4, 2011-01 ,pp. : 467-479

Spandidos Publications

Access to resources Recommend Favorite

Interferon-β treatment associated with a biochemical profile suggestive of acromegaly. A case report of a patient treated for multiple sclerosis

By Andreassen Mikkel   Frystyk Jan   Miller Karen K   Kristensen Lars Ø  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 7, 2010-11 ,pp. : 519-522

Informa Healthcare

Access to resources Recommend Favorite